Search results for "Highlights"
For colonoscopy prep, low-volume, same-day dosing appears as effective as split dosing
A randomized trial of three polyethylene glycol regimens found that more patients tolerated and were willing to repeat low-volume same-day or split-dose prep compared to high-volume split-dose regimens.
https://gastroenterology.acponline.org/archives/2020/08/28/3.htm
28 Aug 2020
Antibiotics may not reduce length of stay in patients hospitalized for uncomplicated diverticulitis
A randomized trial found that median length of hospital stay was 40.0 hours in the antibiotic group and 45.8 hours in the placebo group, with no significant between-group differences in adverse events or readmissions.
https://gastroenterology.acponline.org/archives/2020/04/24/2.htm
24 Apr 2020
Cannabis, cannabinoids didn't improve remission or inflammatory markers in IBD
A meta-analysis of inflammatory bowel disease (IBD) studies did find improvements in patient-reported symptoms and quality of life associated with cannabis and cannabinoids.
https://gastroenterology.acponline.org/archives/2020/07/24/3.htm
24 Jul 2020
Risk and severity of NAFLD differ in men and women
Women have a significantly lower risk of developing nonalcoholic fatty liver disease (NAFLD) but a higher risk of developing advanced fibrosis from NAFLD, according to a systematic review and meta-analysis.
https://gastroenterology.acponline.org/archives/2020/05/22/3.htm
22 May 2020
Model may help identify inpatients with inadequate colon cleansing
Odds of inadequate cleansing were higher in patients who were bedridden or constipated, those with diabetes, those taking antipsychotic drugs, and those hospitalized for seven days or longer.
https://gastroenterology.acponline.org/archives/2020/03/27/3.htm
27 Mar 2020
Patients with IBD who catch COVID-19 have high clot risk, study finds
Infection with SARS-CoV-2 was associated with an eightfold increase in the risk of venous thromboembolism among patients with inflammatory bowel disease (IBD), but the risk was mitigated by chronic anticoagulation, according to a retrospective study.
https://gastroenterology.acponline.org/archives/2021/06/25/1.htm
25 Jun 2021
More concentrated care linked to adverse outcomes in patients with cirrhosis
A retrospective cohort study looked at patients with cirrhosis who were enrolled in Medicare and had had more than four outpatient visits over 180 days.
https://gastroenterology.acponline.org/archives/2020/01/24/2.htm
24 Jan 2020
Recommendations updated on surveillance after colonoscopy and polypectomy
New evidence supports closer follow-up for some patients and less surveillance for others, according to a task force of the American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy.
https://gastroenterology.acponline.org/archives/2020/02/28/2.htm
28 Feb 2020
ACG updates clinical guidelines on prevention, diagnosis, treatment of C. difficile infection
While the American College of Gastroenterology (ACG) included new recommendations for using fecal microbiota transplantation in recurrent Clostridioides difficile infection, it recommended against the use of probiotics for both primary and secondary prevention.
https://gastroenterology.acponline.org/archives/2021/05/28/1.htm
28 May 2021
PPIs in patients receiving anticoagulation may not reduce upper GI events
There was no significant difference in upper GI events between a pantoprazole group and a placebo group, although pantoprazole was associated with significantly reduced bleeding of gastroduodenal lesions, an industry-funded study found.
https://gastroenterology.acponline.org/archives/2019/05/24/3.htm
24 May 2019